etidronate has been researched along with apyrase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bivi, N; Deganuto, M; Moro, L; Pines, A; Quadrifoglio, F; Romanello, M; Tell, G | 1 |
| Aiba, S; Fujimura, T; Furudate, S; Haga, T; Hashimoto, A; Kambayashi, Y | 1 |
2 other study(ies) available for etidronate and apyrase
| Article | Year |
|---|---|
Bisphosphonates activate nucleotide receptors signaling and induce the expression of Hsp90 in osteoblast-like cell lines.
Topics: Adenosine Triphosphate; Alendronate; Apyrase; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Survival; Diphosphonates; Etidronic Acid; HSP90 Heat-Shock Proteins; Humans; Mass Spectrometry; Mitogen-Activated Protein Kinase Kinases; Models, Biological; Osteoblasts; Receptors, Purinergic P2; Risedronic Acid; Signal Transduction; Suramin | 2006 |
Comparison of immunosuppressive and cytotoxic cells in angiosarcoma: development of a possible supportive therapy for angiosarcoma.
Topics: Aged; Aged, 80 and over; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Agents; Apyrase; Docetaxel; Drug Therapy, Combination; Enzyme Inhibitors; Etidronic Acid; Female; Forkhead Transcription Factors; Hemangiosarcoma; Humans; Macrophages; Male; Matrix Metalloproteinase 9; Poly(A)-Binding Proteins; Receptors, Cell Surface; Risedronic Acid; Skin Neoplasms; T-Cell Intracellular Antigen-1; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Taxoids | 2013 |